Morningstar, page-2

From the Morningstar update:
"Although changes to labeling were anticipated, and designed to clarify approved uses and potential side effects of TRT, mandatory laboratory testing by health-care professionals to confirm non-age related low testosterone levels, and the added requirement for manufacturers to conduct well-designed clinical trials to generate robust evidence of risks was not"

How did Morningstar not anticipate that clinical trials and testing "T" levels before prescribing would be required?!? The FDA panel voted 20-1 in favour of that back in September. It was all over the newswires.